European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Human referrals
- Leucomax/Mielogen/SCH34300
Community Register of medicinal products
List of referrals for human medicinal products
Leucomax/Mielogen/SCH34300
| Product name: | Leucomax/Mielogen/SCH34300 |
| Also marketed in the EU under the name(s): | Leucomax, Mielogen, SCH 39300 |
| INN: | molgramostim |
| Indication: | Leucomax is indicated to reduce the risk of infection due toneutropenia in patients treated with cytotoxic chemotherapy for malignant diseases |
| Marketing Authorisation Holder: | Not available |
European Commission procedures
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 28/06/2000 | Referral | EMEA/H/A/283 | (2000)1485 of 27/06/2000 |